nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—glaucoma	0.72	1	CbGaD
Cyproterone acetate—Megestrol acetate—NR3C1—glaucoma	0.00152	0.632	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—glaucoma	0.000886	0.368	CrCbGaD
Cyproterone acetate—Nausea—Methazolamide—glaucoma	0.000251	0.000913	CcSEcCtD
Cyproterone acetate—Hypotension—Dorzolamide—glaucoma	0.000251	0.000912	CcSEcCtD
Cyproterone acetate—Dyspnoea—Brimonidine—glaucoma	0.000251	0.000911	CcSEcCtD
Cyproterone acetate—Mental disorder—Clonidine—glaucoma	0.00025	0.000908	CcSEcCtD
Cyproterone acetate—Hypotension—Travoprost—glaucoma	0.00025	0.000908	CcSEcCtD
Cyproterone acetate—Shock—Pilocarpine—glaucoma	0.00025	0.000907	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Pilocarpine—glaucoma	0.000249	0.000903	CcSEcCtD
Cyproterone acetate—Tachycardia—Pilocarpine—glaucoma	0.000248	0.0009	CcSEcCtD
Cyproterone acetate—Dyspepsia—Brimonidine—glaucoma	0.000248	0.000899	CcSEcCtD
Cyproterone acetate—Hypotension—Brinzolamide—glaucoma	0.000247	0.000896	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Pilocarpine—glaucoma	0.000245	0.000891	CcSEcCtD
Cyproterone acetate—Tension—Clonidine—glaucoma	0.000244	0.000885	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Brimonidine—glaucoma	0.000243	0.000882	CcSEcCtD
Cyproterone acetate—Fatigue—Brimonidine—glaucoma	0.000243	0.000881	CcSEcCtD
Cyproterone acetate—Anorexia—Pilocarpine—glaucoma	0.000242	0.000879	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Acetazolamide—glaucoma	0.000242	0.000877	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Apraclonidine—glaucoma	0.000241	0.000877	CcSEcCtD
Cyproterone acetate—Dyspnoea—Dorzolamide—glaucoma	0.000239	0.00087	CcSEcCtD
Cyproterone acetate—Visual impairment—Betaxolol—glaucoma	0.000239	0.000869	CcSEcCtD
Cyproterone acetate—Dyspnoea—Travoprost—glaucoma	0.000238	0.000866	CcSEcCtD
Cyproterone acetate—Hypotension—Pilocarpine—glaucoma	0.000237	0.000861	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dorzolamide—glaucoma	0.000236	0.000859	CcSEcCtD
Cyproterone acetate—Dyspnoea—Brinzolamide—glaucoma	0.000235	0.000855	CcSEcCtD
Cyproterone acetate—Dyspepsia—Travoprost—glaucoma	0.000235	0.000855	CcSEcCtD
Cyproterone acetate—Asthenia—Apraclonidine—glaucoma	0.000235	0.000854	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dorzolamide—glaucoma	0.000234	0.000848	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Timolol—glaucoma	0.000233	0.000848	CcSEcCtD
Cyproterone acetate—Urticaria—Acetazolamide—glaucoma	0.000233	0.000845	CcSEcCtD
Cyproterone acetate—Dyspepsia—Brinzolamide—glaucoma	0.000232	0.000844	CcSEcCtD
Cyproterone acetate—Eye disorder—Betaxolol—glaucoma	0.000232	0.000843	CcSEcCtD
Cyproterone acetate—Pruritus—Apraclonidine—glaucoma	0.000232	0.000842	CcSEcCtD
Cyproterone acetate—Body temperature increased—Acetazolamide—glaucoma	0.000232	0.000841	CcSEcCtD
Cyproterone acetate—Fatigue—Dorzolamide—glaucoma	0.000232	0.000841	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Travoprost—glaucoma	0.000231	0.000839	CcSEcCtD
Cyproterone acetate—Fatigue—Travoprost—glaucoma	0.000231	0.000837	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Clonidine—glaucoma	0.00023	0.000837	CcSEcCtD
Cyproterone acetate—Decreased appetite—Brinzolamide—glaucoma	0.00023	0.000834	CcSEcCtD
Cyproterone acetate—Weight decreased—Timolol—glaucoma	0.000229	0.000833	CcSEcCtD
Cyproterone acetate—Constipation—Travoprost—glaucoma	0.000229	0.000831	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Timolol—glaucoma	0.000229	0.00083	CcSEcCtD
Cyproterone acetate—Agitation—Clonidine—glaucoma	0.000228	0.000829	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000228	0.000828	CcSEcCtD
Cyproterone acetate—Asthenia—Bimatoprost—glaucoma	0.000228	0.000828	CcSEcCtD
Cyproterone acetate—Fatigue—Brinzolamide—glaucoma	0.000228	0.000827	CcSEcCtD
Cyproterone acetate—Dyspnoea—Pilocarpine—glaucoma	0.000226	0.000822	CcSEcCtD
Cyproterone acetate—Angiopathy—Betaxolol—glaucoma	0.000225	0.000818	CcSEcCtD
Cyproterone acetate—Pruritus—Bimatoprost—glaucoma	0.000225	0.000816	CcSEcCtD
Cyproterone acetate—Immune system disorder—Betaxolol—glaucoma	0.000224	0.000815	CcSEcCtD
Cyproterone acetate—Diarrhoea—Apraclonidine—glaucoma	0.000224	0.000814	CcSEcCtD
Cyproterone acetate—Malaise—Clonidine—glaucoma	0.000224	0.000813	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Betaxolol—glaucoma	0.000224	0.000813	CcSEcCtD
Cyproterone acetate—Dyspepsia—Pilocarpine—glaucoma	0.000223	0.000811	CcSEcCtD
Cyproterone acetate—Chills—Betaxolol—glaucoma	0.000223	0.000809	CcSEcCtD
Cyproterone acetate—Syncope—Clonidine—glaucoma	0.000223	0.000809	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dorzolamide—glaucoma	0.000221	0.000804	CcSEcCtD
Cyproterone acetate—Decreased appetite—Pilocarpine—glaucoma	0.000221	0.000801	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Travoprost—glaucoma	0.00022	0.0008	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dorzolamide—glaucoma	0.00022	0.000798	CcSEcCtD
Cyproterone acetate—Alopecia—Betaxolol—glaucoma	0.000219	0.000797	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000219	0.000796	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Travoprost—glaucoma	0.000219	0.000794	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Clonidine—glaucoma	0.000218	0.000793	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Brinzolamide—glaucoma	0.000218	0.00079	CcSEcCtD
Cyproterone acetate—Mental disorder—Betaxolol—glaucoma	0.000218	0.00079	CcSEcCtD
Cyproterone acetate—Constipation—Pilocarpine—glaucoma	0.000217	0.000788	CcSEcCtD
Cyproterone acetate—Cough—Clonidine—glaucoma	0.000217	0.000787	CcSEcCtD
Cyproterone acetate—Sweating—Timolol—glaucoma	0.000217	0.000787	CcSEcCtD
Cyproterone acetate—Dizziness—Apraclonidine—glaucoma	0.000217	0.000787	CcSEcCtD
Cyproterone acetate—Malnutrition—Betaxolol—glaucoma	0.000216	0.000785	CcSEcCtD
Cyproterone acetate—Urticaria—Dorzolamide—glaucoma	0.000213	0.000775	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dorzolamide—glaucoma	0.000212	0.000771	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dorzolamide—glaucoma	0.000212	0.000771	CcSEcCtD
Cyproterone acetate—Tension—Betaxolol—glaucoma	0.000212	0.000771	CcSEcCtD
Cyproterone acetate—Abdominal pain—Travoprost—glaucoma	0.000211	0.000768	CcSEcCtD
Cyproterone acetate—Asthenia—Acetazolamide—glaucoma	0.00021	0.000764	CcSEcCtD
Cyproterone acetate—Dizziness—Bimatoprost—glaucoma	0.00021	0.000763	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00021	0.000763	CcSEcCtD
Cyproterone acetate—Urticaria—Brinzolamide—glaucoma	0.00021	0.000762	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Pilocarpine—glaucoma	0.000209	0.00076	CcSEcCtD
Cyproterone acetate—Discomfort—Clonidine—glaucoma	0.000209	0.000759	CcSEcCtD
Cyproterone acetate—Vomiting—Apraclonidine—glaucoma	0.000208	0.000756	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000208	0.000754	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Brimonidine—glaucoma	0.000207	0.000753	CcSEcCtD
Cyproterone acetate—Dermatitis—Apraclonidine—glaucoma	0.000206	0.000749	CcSEcCtD
Cyproterone acetate—Headache—Apraclonidine—glaucoma	0.000205	0.000745	CcSEcCtD
Cyproterone acetate—Oedema—Clonidine—glaucoma	0.000203	0.000736	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—PITX2—glaucoma	0.000202	0.0745	CbGpPWpGaD
Cyproterone acetate—Asthenia—Brimonidine—glaucoma	0.000202	0.000733	CcSEcCtD
Cyproterone acetate—Body temperature increased—Pilocarpine—glaucoma	0.000201	0.000729	CcSEcCtD
Cyproterone acetate—Abdominal pain—Pilocarpine—glaucoma	0.000201	0.000729	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Betaxolol—glaucoma	0.000201	0.000729	CcSEcCtD
Cyproterone acetate—Diarrhoea—Acetazolamide—glaucoma	0.000201	0.000728	CcSEcCtD
Cyproterone acetate—Rash—Bimatoprost—glaucoma	0.0002	0.000727	CcSEcCtD
Cyproterone acetate—Dermatitis—Bimatoprost—glaucoma	0.0002	0.000727	CcSEcCtD
Cyproterone acetate—Anaemia—Betaxolol—glaucoma	0.0002	0.000726	CcSEcCtD
Cyproterone acetate—Shock—Clonidine—glaucoma	0.000199	0.000724	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Timolol—glaucoma	0.000199	0.000724	CcSEcCtD
Cyproterone acetate—Pruritus—Brimonidine—glaucoma	0.000199	0.000723	CcSEcCtD
Cyproterone acetate—Headache—Bimatoprost—glaucoma	0.000199	0.000723	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Clonidine—glaucoma	0.000199	0.000722	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Clonidine—glaucoma	0.000198	0.000721	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Dorzolamide—glaucoma	0.000198	0.000719	CcSEcCtD
Cyproterone acetate—Tachycardia—Clonidine—glaucoma	0.000198	0.000718	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Travoprost—glaucoma	0.000197	0.000716	CcSEcCtD
Cyproterone acetate—Skin disorder—Clonidine—glaucoma	0.000197	0.000715	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Clonidine—glaucoma	0.000196	0.000712	CcSEcCtD
Cyproterone acetate—Visual impairment—Timolol—glaucoma	0.000196	0.00071	CcSEcCtD
Cyproterone acetate—Malaise—Betaxolol—glaucoma	0.000195	0.000708	CcSEcCtD
Cyproterone acetate—Nausea—Apraclonidine—glaucoma	0.000195	0.000707	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Brinzolamide—glaucoma	0.000195	0.000707	CcSEcCtD
Cyproterone acetate—Syncope—Betaxolol—glaucoma	0.000194	0.000704	CcSEcCtD
Cyproterone acetate—Dizziness—Acetazolamide—glaucoma	0.000194	0.000704	CcSEcCtD
Cyproterone acetate—Anorexia—Clonidine—glaucoma	0.000193	0.000702	CcSEcCtD
Cyproterone acetate—Asthenia—Dorzolamide—glaucoma	0.000193	0.0007	CcSEcCtD
Cyproterone acetate—Asthenia—Travoprost—glaucoma	0.000192	0.000697	CcSEcCtD
Cyproterone acetate—Pruritus—Dorzolamide—glaucoma	0.00019	0.00069	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Betaxolol—glaucoma	0.00019	0.00069	CcSEcCtD
Cyproterone acetate—Eye disorder—Timolol—glaucoma	0.00019	0.000689	CcSEcCtD
Cyproterone acetate—Asthenia—Brinzolamide—glaucoma	0.000189	0.000688	CcSEcCtD
Cyproterone acetate—Hypotension—Clonidine—glaucoma	0.000189	0.000688	CcSEcCtD
Cyproterone acetate—Pruritus—Travoprost—glaucoma	0.000189	0.000687	CcSEcCtD
Cyproterone acetate—Cough—Betaxolol—glaucoma	0.000189	0.000685	CcSEcCtD
Cyproterone acetate—Nausea—Bimatoprost—glaucoma	0.000189	0.000685	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Pilocarpine—glaucoma	0.000187	0.000679	CcSEcCtD
Cyproterone acetate—Pruritus—Brinzolamide—glaucoma	0.000187	0.000679	CcSEcCtD
Cyproterone acetate—Vomiting—Acetazolamide—glaucoma	0.000186	0.000677	CcSEcCtD
Cyproterone acetate—Dizziness—Brimonidine—glaucoma	0.000186	0.000675	CcSEcCtD
Cyproterone acetate—Angiopathy—Timolol—glaucoma	0.000184	0.000669	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dorzolamide—glaucoma	0.000184	0.000667	CcSEcCtD
Cyproterone acetate—Headache—Acetazolamide—glaucoma	0.000184	0.000667	CcSEcCtD
Cyproterone acetate—Immune system disorder—Timolol—glaucoma	0.000183	0.000666	CcSEcCtD
Cyproterone acetate—Diarrhoea—Travoprost—glaucoma	0.000183	0.000665	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Timolol—glaucoma	0.000183	0.000664	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000183	0.000664	CcSEcCtD
Cyproterone acetate—Asthenia—Pilocarpine—glaucoma	0.000182	0.000661	CcSEcCtD
Cyproterone acetate—Discomfort—Betaxolol—glaucoma	0.000182	0.000661	CcSEcCtD
Cyproterone acetate—Dyspnoea—Clonidine—glaucoma	0.000181	0.000656	CcSEcCtD
Cyproterone acetate—Diarrhoea—Brinzolamide—glaucoma	0.000181	0.000656	CcSEcCtD
Cyproterone acetate—Pruritus—Pilocarpine—glaucoma	0.00018	0.000652	CcSEcCtD
Cyproterone acetate—Alopecia—Timolol—glaucoma	0.000179	0.000651	CcSEcCtD
Cyproterone acetate—Mental disorder—Timolol—glaucoma	0.000178	0.000646	CcSEcCtD
Cyproterone acetate—Dizziness—Dorzolamide—glaucoma	0.000178	0.000645	CcSEcCtD
Cyproterone acetate—Rash—Brimonidine—glaucoma	0.000177	0.000644	CcSEcCtD
Cyproterone acetate—Dermatitis—Brimonidine—glaucoma	0.000177	0.000643	CcSEcCtD
Cyproterone acetate—Dizziness—Travoprost—glaucoma	0.000177	0.000642	CcSEcCtD
Cyproterone acetate—Malnutrition—Timolol—glaucoma	0.000177	0.000641	CcSEcCtD
Cyproterone acetate—Oedema—Betaxolol—glaucoma	0.000176	0.000641	CcSEcCtD
Cyproterone acetate—Headache—Brimonidine—glaucoma	0.000176	0.00064	CcSEcCtD
Cyproterone acetate—Decreased appetite—Clonidine—glaucoma	0.000176	0.00064	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Clonidine—glaucoma	0.000175	0.000636	CcSEcCtD
Cyproterone acetate—Fatigue—Clonidine—glaucoma	0.000175	0.000635	CcSEcCtD
Cyproterone acetate—Dizziness—Brinzolamide—glaucoma	0.000175	0.000634	CcSEcCtD
Cyproterone acetate—Nausea—Acetazolamide—glaucoma	0.000174	0.000632	CcSEcCtD
Cyproterone acetate—Diarrhoea—Pilocarpine—glaucoma	0.000174	0.000631	CcSEcCtD
Cyproterone acetate—Shock—Betaxolol—glaucoma	0.000174	0.000631	CcSEcCtD
Cyproterone acetate—Tension—Timolol—glaucoma	0.000173	0.000629	CcSEcCtD
Cyproterone acetate—Constipation—Clonidine—glaucoma	0.000173	0.000629	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Betaxolol—glaucoma	0.000173	0.000628	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Betaxolol—glaucoma	0.000173	0.000627	CcSEcCtD
Cyproterone acetate—Tachycardia—Betaxolol—glaucoma	0.000172	0.000625	CcSEcCtD
Cyproterone acetate—Skin disorder—Betaxolol—glaucoma	0.000171	0.000622	CcSEcCtD
Cyproterone acetate—Vomiting—Dorzolamide—glaucoma	0.000171	0.00062	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Betaxolol—glaucoma	0.000171	0.00062	CcSEcCtD
Cyproterone acetate—Rash—Dorzolamide—glaucoma	0.000169	0.000615	CcSEcCtD
Cyproterone acetate—Dermatitis—Dorzolamide—glaucoma	0.000169	0.000615	CcSEcCtD
Cyproterone acetate—Rash—Travoprost—glaucoma	0.000169	0.000612	CcSEcCtD
Cyproterone acetate—Dermatitis—Travoprost—glaucoma	0.000168	0.000612	CcSEcCtD
Cyproterone acetate—Headache—Dorzolamide—glaucoma	0.000168	0.000611	CcSEcCtD
Cyproterone acetate—Anorexia—Betaxolol—glaucoma	0.000168	0.000611	CcSEcCtD
Cyproterone acetate—Vomiting—Brinzolamide—glaucoma	0.000168	0.00061	CcSEcCtD
Cyproterone acetate—Dizziness—Pilocarpine—glaucoma	0.000168	0.00061	CcSEcCtD
Cyproterone acetate—Headache—Travoprost—glaucoma	0.000168	0.000608	CcSEcCtD
Cyproterone acetate—Nausea—Brimonidine—glaucoma	0.000167	0.000607	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Clonidine—glaucoma	0.000167	0.000607	CcSEcCtD
Cyproterone acetate—Rash—Brinzolamide—glaucoma	0.000167	0.000605	CcSEcCtD
Cyproterone acetate—Dermatitis—Brinzolamide—glaucoma	0.000166	0.000604	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Clonidine—glaucoma	0.000166	0.000602	CcSEcCtD
Cyproterone acetate—Headache—Brinzolamide—glaucoma	0.000165	0.000601	CcSEcCtD
Cyproterone acetate—Hypotension—Betaxolol—glaucoma	0.000165	0.000599	CcSEcCtD
Cyproterone acetate—Vomiting—Pilocarpine—glaucoma	0.000161	0.000586	CcSEcCtD
Cyproterone acetate—Urticaria—Clonidine—glaucoma	0.000161	0.000585	CcSEcCtD
Cyproterone acetate—Abdominal pain—Clonidine—glaucoma	0.00016	0.000582	CcSEcCtD
Cyproterone acetate—Body temperature increased—Clonidine—glaucoma	0.00016	0.000582	CcSEcCtD
Cyproterone acetate—Rash—Pilocarpine—glaucoma	0.00016	0.000581	CcSEcCtD
Cyproterone acetate—Dermatitis—Pilocarpine—glaucoma	0.00016	0.000581	CcSEcCtD
Cyproterone acetate—Nausea—Dorzolamide—glaucoma	0.00016	0.000579	CcSEcCtD
Cyproterone acetate—Headache—Pilocarpine—glaucoma	0.000159	0.000577	CcSEcCtD
Cyproterone acetate—Nausea—Travoprost—glaucoma	0.000159	0.000577	CcSEcCtD
Cyproterone acetate—Syncope—Timolol—glaucoma	0.000158	0.000575	CcSEcCtD
Cyproterone acetate—Dyspnoea—Betaxolol—glaucoma	0.000157	0.000571	CcSEcCtD
Cyproterone acetate—Nausea—Brinzolamide—glaucoma	0.000157	0.00057	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betaxolol—glaucoma	0.000155	0.000564	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Timolol—glaucoma	0.000155	0.000564	CcSEcCtD
Cyproterone acetate—Cough—Timolol—glaucoma	0.000154	0.00056	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betaxolol—glaucoma	0.000153	0.000557	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betaxolol—glaucoma	0.000152	0.000553	CcSEcCtD
Cyproterone acetate—Fatigue—Betaxolol—glaucoma	0.000152	0.000553	CcSEcCtD
Cyproterone acetate—Constipation—Betaxolol—glaucoma	0.000151	0.000548	CcSEcCtD
Cyproterone acetate—Nausea—Pilocarpine—glaucoma	0.000151	0.000548	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000149	0.000542	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Clonidine—glaucoma	0.000149	0.000542	CcSEcCtD
Cyproterone acetate—Discomfort—Timolol—glaucoma	0.000149	0.00054	CcSEcCtD
Cyproterone acetate—Asthenia—Clonidine—glaucoma	0.000145	0.000528	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betaxolol—glaucoma	0.000145	0.000528	CcSEcCtD
Cyproterone acetate—Oedema—Timolol—glaucoma	0.000144	0.000524	CcSEcCtD
Cyproterone acetate—Pruritus—Clonidine—glaucoma	0.000143	0.000521	CcSEcCtD
Cyproterone acetate—Shock—Timolol—glaucoma	0.000142	0.000515	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Timolol—glaucoma	0.000141	0.000513	CcSEcCtD
Cyproterone acetate—Urticaria—Betaxolol—glaucoma	0.00014	0.000509	CcSEcCtD
Cyproterone acetate—Skin disorder—Timolol—glaucoma	0.00014	0.000509	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betaxolol—glaucoma	0.00014	0.000507	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Timolol—glaucoma	0.000139	0.000506	CcSEcCtD
Cyproterone acetate—Diarrhoea—Clonidine—glaucoma	0.000139	0.000504	CcSEcCtD
Cyproterone acetate—Anorexia—Timolol—glaucoma	0.000137	0.000499	CcSEcCtD
Cyproterone acetate—Hypotension—Timolol—glaucoma	0.000135	0.000489	CcSEcCtD
Cyproterone acetate—Dizziness—Clonidine—glaucoma	0.000134	0.000487	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Betaxolol—glaucoma	0.00013	0.000472	CcSEcCtD
Cyproterone acetate—Vomiting—Clonidine—glaucoma	0.000129	0.000468	CcSEcCtD
Cyproterone acetate—Dyspnoea—Timolol—glaucoma	0.000129	0.000467	CcSEcCtD
Cyproterone acetate—Rash—Clonidine—glaucoma	0.000128	0.000464	CcSEcCtD
Cyproterone acetate—Dermatitis—Clonidine—glaucoma	0.000128	0.000464	CcSEcCtD
Cyproterone acetate—Headache—Clonidine—glaucoma	0.000127	0.000461	CcSEcCtD
Cyproterone acetate—Dyspepsia—Timolol—glaucoma	0.000127	0.000461	CcSEcCtD
Cyproterone acetate—Asthenia—Betaxolol—glaucoma	0.000127	0.00046	CcSEcCtD
Cyproterone acetate—Decreased appetite—Timolol—glaucoma	0.000125	0.000455	CcSEcCtD
Cyproterone acetate—Pruritus—Betaxolol—glaucoma	0.000125	0.000453	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Timolol—glaucoma	0.000124	0.000452	CcSEcCtD
Cyproterone acetate—Fatigue—Timolol—glaucoma	0.000124	0.000451	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betaxolol—glaucoma	0.000121	0.000438	CcSEcCtD
Cyproterone acetate—Nausea—Clonidine—glaucoma	0.00012	0.000437	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Timolol—glaucoma	0.000119	0.000431	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000118	0.0437	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Timolol—glaucoma	0.000118	0.000428	CcSEcCtD
Cyproterone acetate—Dizziness—Betaxolol—glaucoma	0.000117	0.000424	CcSEcCtD
Cyproterone acetate—Urticaria—Timolol—glaucoma	0.000115	0.000416	CcSEcCtD
Cyproterone acetate—Abdominal pain—Timolol—glaucoma	0.000114	0.000414	CcSEcCtD
Cyproterone acetate—Body temperature increased—Timolol—glaucoma	0.000114	0.000414	CcSEcCtD
Cyproterone acetate—Vomiting—Betaxolol—glaucoma	0.000112	0.000407	CcSEcCtD
Cyproterone acetate—Rash—Betaxolol—glaucoma	0.000111	0.000404	CcSEcCtD
Cyproterone acetate—Dermatitis—Betaxolol—glaucoma	0.000111	0.000404	CcSEcCtD
Cyproterone acetate—Headache—Betaxolol—glaucoma	0.000111	0.000401	CcSEcCtD
Cyproterone acetate—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.000108	0.0397	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Timolol—glaucoma	0.000106	0.000386	CcSEcCtD
Cyproterone acetate—Nausea—Betaxolol—glaucoma	0.000105	0.000381	CcSEcCtD
Cyproterone acetate—Asthenia—Timolol—glaucoma	0.000103	0.000376	CcSEcCtD
Cyproterone acetate—Pruritus—Timolol—glaucoma	0.000102	0.00037	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000101	0.0371	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	9.96e-05	0.0367	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Timolol—glaucoma	9.86e-05	0.000358	CcSEcCtD
Cyproterone acetate—Dizziness—Timolol—glaucoma	9.53e-05	0.000346	CcSEcCtD
Cyproterone acetate—Vomiting—Timolol—glaucoma	9.17e-05	0.000333	CcSEcCtD
Cyproterone acetate—Rash—Timolol—glaucoma	9.09e-05	0.00033	CcSEcCtD
Cyproterone acetate—Dermatitis—Timolol—glaucoma	9.08e-05	0.00033	CcSEcCtD
Cyproterone acetate—Headache—Timolol—glaucoma	9.03e-05	0.000328	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	8.98e-05	0.0331	CbGpPWpGaD
Cyproterone acetate—Nausea—Timolol—glaucoma	8.56e-05	0.000311	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—BDNF—glaucoma	7.93e-05	0.0293	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	7.77e-05	0.0287	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—SOD1—glaucoma	6.64e-05	0.0245	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—NR3C1—glaucoma	6.19e-05	0.0229	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	6.18e-05	0.0228	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5e-05	0.0184	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.93e-05	0.0182	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	4.89e-05	0.0181	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	4.75e-05	0.0175	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	4.34e-05	0.016	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	4.24e-05	0.0157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.05e-05	0.015	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	3.85e-05	0.0142	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	3.53e-05	0.013	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	3.38e-05	0.0125	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	3.22e-05	0.0119	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	3.18e-05	0.0117	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	3.15e-05	0.0116	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	3.04e-05	0.0112	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	3.02e-05	0.0111	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	2.99e-05	0.011	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	2.92e-05	0.0108	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	2.82e-05	0.0104	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	2.76e-05	0.0102	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CAV1—glaucoma	2.76e-05	0.0102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTT1—glaucoma	2.7e-05	0.00997	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	2.65e-05	0.00977	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	2.43e-05	0.00896	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	2.33e-05	0.00861	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	2.3e-05	0.0085	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	2.27e-05	0.00836	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	2.22e-05	0.00821	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	2.18e-05	0.00803	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1B1—glaucoma	2.15e-05	0.00794	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	2.12e-05	0.00784	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.1e-05	0.00777	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.01e-05	0.00742	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NGF—glaucoma	2.01e-05	0.00742	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	2e-05	0.00738	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.94e-05	0.00716	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.93e-05	0.00711	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NARFL—glaucoma	1.89e-05	0.00699	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA5A—glaucoma	1.89e-05	0.00699	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	1.89e-05	0.00697	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	1.88e-05	0.00693	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	1.82e-05	0.00673	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—glaucoma	1.72e-05	0.00635	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	1.72e-05	0.00634	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	1.7e-05	0.00628	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—glaucoma	1.7e-05	0.00628	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	1.7e-05	0.00626	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	1.66e-05	0.00614	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	1.65e-05	0.00609	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.65e-05	0.00608	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	1.62e-05	0.00599	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	1.54e-05	0.00569	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	1.53e-05	0.00563	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	1.46e-05	0.0054	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.41e-05	0.0052	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—glaucoma	1.05e-05	0.00386	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.04e-05	0.00383	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	9.86e-06	0.00364	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	9.82e-06	0.00362	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—glaucoma	9.63e-06	0.00355	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	9.6e-06	0.00354	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA1—glaucoma	9.25e-06	0.00341	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	9.21e-06	0.0034	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CTSA—glaucoma	8.96e-06	0.00331	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	8.48e-06	0.00313	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA2—glaucoma	8.46e-06	0.00312	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—glaucoma	8.45e-06	0.00312	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.27e-06	0.00305	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.27e-06	0.00305	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—glaucoma	8.23e-06	0.00304	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	8.17e-06	0.00301	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	7.45e-06	0.00275	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	7.31e-06	0.0027	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.29e-06	0.00269	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—glaucoma	7.23e-06	0.00267	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7e-06	0.00258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	6.41e-06	0.00237	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	6.24e-06	0.0023	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.17e-06	0.00228	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TXN—glaucoma	5.96e-06	0.0022	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.44e-06	0.00201	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.39e-06	0.00199	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CDKN2B—glaucoma	4.64e-06	0.00171	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—glaucoma	4.62e-06	0.00171	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—glaucoma	4.07e-06	0.0015	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.73e-06	0.00137	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCA1—glaucoma	3.68e-06	0.00136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1B1—glaucoma	3.68e-06	0.00136	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—glaucoma	3.52e-06	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—glaucoma	2.94e-06	0.00109	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—glaucoma	2.6e-06	0.00096	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—glaucoma	2.42e-06	0.000894	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—glaucoma	2.4e-06	0.000885	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—glaucoma	1.81e-06	0.00067	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—glaucoma	1.66e-06	0.000612	CbGpPWpGaD
